Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tamsulosin 0.4 mg Continuation Versus Dose Escalation to 0.8 mg Versus Switch to Silodosin 8 mg for Trial Without Catheter After Acute Urinary Retention Due to Benign Prostatic Hyperplasia: A Randomized Controlled Trial

NCT07650968 is registered in ClinicalTrials.gov with Beni-Suef University as lead sponsor.

NCT NCT07650968
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07650968 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tamsulosin 0.4 mg Continuation Versus Dose Escalation to 0.8 mg Versus Switch to Silodosin 8 mg for Trial Without Catheter After Acute Urinary Retention Due to Benign Prostatic Hyperplasia: A Randomized Controlled Trial
Lead sponsor
Beni-Suef University
Phase
Phase 4
Overall status
Recruiting
Start date
June 8, 2026
Completion date
June 30, 2027
Enrollment
378 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute urinary retention, benign prostatic hyperplasia